Markets Gone Wild

Venture Global, Inc. (NYSE:VG) Investors: Understanding Your Potential Recovery Options If you’ve recently experienced financial losses due to your investment in Venture Global, Inc. (NYSE:VG), you’re not alone. The stock market can be an unpredictable beast, and even the most well-researched investments can sometimes result in less-than-desirable outcomes. But what can you do about it?…

Exciting News from Q32 Bio Inc. at ASN Kidney Week 2024 Poster Presentation Highlights Data from ADX-097 Clinical Trial At the upcoming American Society of Nephrology (ASN) Kidney Week 2024, Q32 Bio Inc. will be presenting data from a completed Phase 1 ascending dose clinical trial of ADX-097 in healthy volunteers. The results of this…

Sprinklr Faces Class Action Lawsuit for Alleged Securities Violations New York, NY / Accesswire / September 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sprinklr, Inc. (“Sprinklr” or “the Company”) (NYSE:CXM) and certain of its officers. Class Definition This…

The Impact of Cassava Sciences Investigation on Investors Investigation Commenced Levi & Korsinsky has recently started investigating Cassava Sciences, Inc. (NASDAQ: SAVA) for potential violations of federal securities laws. This investigation comes after Cassava Sciences announced on November 25, 2024, that the topline results from the Phase 3 ReThink-ALZ study of simufilam in mild-to-moderate Alzheimer’s…